Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.720
-0.070 (-2.51%)
Sep 25, 2025, 2:52 PM EDT - Market open
Neuronetics Market Cap
Neuronetics has a market cap or net worth of $179.86 million as of September 25, 2025. Its market cap has increased by 661.13% in one year.
Market Cap
179.86M
Enterprise Value
254.18M
1-Year Change
661.13%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $464.84M to $179.86M, a decrease of -61.31%. That is a compound annual growth rate of -12.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2025 | 184.49M | 105.90% |
| Dec 31, 2024 | 89.60M | 6.79% |
| Dec 29, 2023 | 83.91M | -55.13% |
| Dec 30, 2022 | 187.01M | 59.02% |
| Dec 31, 2021 | 117.60M | -44.22% |
| Dec 31, 2020 | 210.82M | 151.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.59B |
| Johnson & Johnson | 425.26B |
| AbbVie | 393.25B |
| UnitedHealth Group | 314.89B |
| Novo Nordisk | 262.84B |
| Novartis AG | 238.07B |
| Abbott Laboratories | 236.51B |
| AstraZeneca | 235.93B |